University of Illinois at Chicago, Division of Epidemiology and Biostatistics.
University of Oklahoma.
J Gerontol A Biol Sci Med Sci. 2019 Nov 13;74(Suppl_1):S7-S12. doi: 10.1093/gerona/glz098.
The rise in human longevity is one of humanity's crowning achievements. Although advances in public health beginning in the 19th century initiated the rise in life expectancy, recent gains have been achieved by reducing death rates at middle and older ages. A debate about the future course of life expectancy has been ongoing for the last quarter century. Some suggest that historical trends in longevity will continue and radical life extension is either visible on the near horizon or it has already arrived; whereas others suggest there are biologically based limits to duration of life, and those limits are being approached now. In "inconvenient truths about human longevity" we lay out the line of reasoning and evidence for why there are limits to human longevity; why predictions of radical life extension are unlikely to be forthcoming; why health extension should supplant life extension as the primary goal of medicine and public health; and why promoting advances in aging biology may allow humanity to break through biological barriers that influence both life span and health span, allowing for a welcome extension of the period of healthy life, a compression of morbidity, but only a marginal further increase in life expectancy.
人类寿命的延长是人类最伟大的成就之一。虽然 19 世纪开始的公共卫生进步引发了预期寿命的延长,但最近的增长是通过降低中老年人的死亡率实现的。关于预期寿命未来走向的争论已经持续了四分之一个世纪。一些人认为,长寿的历史趋势将继续下去,激进的寿命延长要么就在眼前,要么已经到来;而另一些人则认为,生命的持续时间存在基于生物学的限制,而且这些限制现在已经接近了。在“关于人类寿命的不为人知的事实”中,我们阐述了为什么人类的寿命存在限制的推理和证据;为什么激进的寿命延长的预测不太可能出现;为什么健康的延长应该取代寿命的延长成为医学和公共卫生的主要目标;以及为什么促进衰老生物学的进步可能使人类突破影响寿命和健康寿命的生物学障碍,从而延长健康寿命的时间段,缩短发病期,但只能使预期寿命略有进一步延长。